Without prejudice to any other provision contained in this Chapter, if the Central Government is satisfied, that the use of any drug or cosmetic is likely to involve any risk to human beings or animals or that any drug does not have the therapeutic value claimed or purported to be claimed for it or contains ingredients and in such quantity for which there is no therapeutic justification and that in the public interest it is necessary or expedient so to do, then, that Government may, by notification in the Official Gazette, 2 [regulate, restrict or prohibit] the manufacture, sale or distribution of such drug or cosmetic.]
----------------
1. Ins. by Act 68 of 1982. s. 21 (w.e.f. 1-2-1983).
2. Subs. by Act 26 of 2008, s. 4, for "prohibit" (w.e.f. 10-8-2009).
Section 16 Standards of quality
Section 17C Misbranded cosmetics
Section 17D Spurious cosmetics
Section 17E Adulterated cosmetics
Section 18 Prohibition of manufacture and sale of certain drugs and cosmetics
Section 18A Disclosure of the name of the manufacturer, etc
Section 18B Maintenance of records and furnishing of information
Section 20 Government Analysts
Section 22 Powers of Inspectors
Section 23 Procedure of Inspectors
Section 24 Persons bound to disclose place where drugs or cosmetics are manufactured or kept
Section 25 Reports of Government Analysts
Section 26 Purchaser of drug or cosmetic enabled to obtain test or analysis
Section 27 Penalty for manufacture, sale, etc., of drugs in contravention of this Chapter
Section 27A Penalty for manufacture, sale, etc., of cosmetics in contravention of this Chapter
Section 28 Penalty for non-disclosure of the name of the manufacturer, etc
Section 28A Penalty for not keeping documents, etc., and for non-disclosure of information
Section 28B Penalty for manufacture, etc., of drugs or cosmetics in contravention of section 26A
Section 29 Penalty for use of Government Analyst's report for advertising